Leah N. Klapper

2.6k total citations · 1 hit paper
17 papers, 2.2k citations indexed

About

Leah N. Klapper is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Leah N. Klapper has authored 17 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 12 papers in Molecular Biology and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Leah N. Klapper's work include HER2/EGFR in Cancer Research (9 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Glycosylation and Glycoproteins Research (6 papers). Leah N. Klapper is often cited by papers focused on HER2/EGFR in Cancer Research (9 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Glycosylation and Glycoproteins Research (6 papers). Leah N. Klapper collaborates with scholars based in Israel, United States and Netherlands. Leah N. Klapper's co-authors include Yosef Yarden, Michael Sela, Mark Kirschbaum, Ronit Pinkas‐Kramarski, Nora Vaisman, Gil Levkowitz, Sara Lavi, Hadassa Waterman, Lior Soussan and Iris Alroy and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The EMBO Journal.

In The Last Decade

Leah N. Klapper

16 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions.

1996 645 citations Ronit Pinkas‐Kramarski, Lior Soussan et al. The EMBO Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Leah N. Klapper Israel	13	1.6k	1.1k	982	312	270	17	2.2k
M H Kraus United States	15	1.8k 1.2×	1.5k 1.4×	1.2k 1.2×	219 0.7×	186 0.7×	17	2.5k
Maria Niewolna United States	18	1.2k 0.8×	1.0k 0.9×	290 0.3×	351 1.1×	134 0.5×	23	2.0k
Maria Sundvall Finland	20	949 0.6×	1.2k 1.1×	364 0.4×	303 1.0×	97 0.4×	33	1.8k
Antonella Zannetti Italy	27	669 0.4×	1.1k 1.0×	278 0.3×	177 0.6×	240 0.9×	66	2.0k
Gianluca Sala Italy	24	761 0.5×	1.1k 1.0×	336 0.3×	213 0.7×	240 0.9×	64	1.9k
Andreas Menrad Germany	20	513 0.3×	682 0.6×	280 0.3×	117 0.4×	267 1.0×	30	1.5k
Evelyn Yao United States	11	935 0.6×	1.3k 1.2×	395 0.4×	192 0.6×	233 0.9×	12	2.3k
Kalyani Penta United States	15	487 0.3×	955 0.9×	341 0.3×	60 0.2×	271 1.0×	21	1.6k
Christine Tan United States	10	487 0.3×	1.2k 1.1×	272 0.3×	143 0.5×	318 1.2×	17	1.9k
Lily Yen United States	17	639 0.4×	861 0.8×	245 0.2×	109 0.3×	101 0.4×	18	1.3k

Countries citing papers authored by Leah N. Klapper

Since Specialization

Citations

This map shows the geographic impact of Leah N. Klapper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leah N. Klapper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leah N. Klapper more than expected).

Fields of papers citing papers by Leah N. Klapper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leah N. Klapper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leah N. Klapper. The network helps show where Leah N. Klapper may publish in the future.

Co-authorship network of co-authors of Leah N. Klapper

This figure shows the co-authorship network connecting the top 25 collaborators of Leah N. Klapper. A scholar is included among the top collaborators of Leah N. Klapper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leah N. Klapper. Leah N. Klapper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Bracha, Moshe, S. Shavit, Roy Avraham, et al.. (2025). Mouse B cells engineered to express an anti-HPV antibody elicit anti-tumor T cell responses.. PubMed. 16. 1613879–1613879.

Cheung, Wai W., Wei Ding, Yong Gu, et al.. (2013). A Pegylated Leptin Antagonist Ameliorates CKD-Associated Cachexia in Mice. Journal of the American Society of Nephrology. 25(1). 119–128. 31 indexed citations

Tavor, Sigal, Ido D. Weiss, Katia Beider, et al.. (2013). The CXCR4 Antagonist BL-8040 Efficiently Induces Apoptosis and Inhibits The Survival Of AML Cells. Blood. 122(21). 3939–3939. 4 indexed citations

Levy‐Nissenbaum, Etgar, Wahid Khan, Rajendra P. Pawar, et al.. (2012). Pharmacokinetic and efficacy study of cisplatin and paclitaxel formulated in a new injectable poly(sebacic-co-ricinoleic acid) polymer. European Journal of Pharmaceutics and Biopharmaceutics. 82(1). 85–93. 12 indexed citations

Izhak, Liat, Gizi Wildbaum, Yaniv Zohar, et al.. (2009). A Novel Recombinant Fusion Protein Encoding a 20-Amino Acid Residue of the Third Extracellular (E3) Domain of CCR2 Neutralizes the Biological Activity of CCL2. The Journal of Immunology. 183(1). 732–739. 24 indexed citations

Nudelman, Abraham, Irit Gil‐Ad, Ada Rephaeli, et al.. (2008). BL-1020: A novel antipsychotic drug with GABAergic activity and low catalepsy, is efficacious in a rat model of schizophrenia. European Neuropsychopharmacology. 19(1). 1–13. 28 indexed citations

Quaglino, Elena, Cristina Mastini, Manuela Iezzi, et al.. (2005). The adjuvant activity of BAT antibody enables DNA vaccination to inhibit the progression of established autochthonous Her-2/neu carcinomas in BALB/c mice. Vaccine. 23(25). 3280–3287. 17 indexed citations

Levkowitz, Gil, Shlomo Oved, Leah N. Klapper, et al.. (2000). c-Cbl Is a Suppressor of the Neu Oncogene. Journal of Biological Chemistry. 275(45). 35532–35539. 65 indexed citations

Klapper, Leah N., Hadassa Waterman, Michael Sela, & Yosef Yarden. (2000). Tumor-inhibitory antibodies to HER-2/ErbB-2 may act by recruiting c-Cbl and enhancing ubiquitination of HER-2.. PubMed. 60(13). 3384–8. 269 indexed citations

10.

Hurwitz, Esther, Leah N. Klapper, Meir Wilchek, Yosef Yarden, & Michael Sela. (2000). Inhibition of tumor growth by poly(ethylene glycol) derivatives of anti-ErbB2 antibodies. Cancer Immunology Immunotherapy. 49(4-5). 226–234. 22 indexed citations

11.

Vaisman, Nora, Ahuva Nissim, Leah N. Klapper, et al.. (2000). Specific inhibition of the reaction between a tumor-inhibitory antibody and the ErbB-2 receptor by a mimotope derived from a phage display library. Immunology Letters. 75(1). 61–67. 12 indexed citations

12.

Klapper, Leah N., et al.. (1999). Biochemical and Clinical Implications of the ErbB/HER Signaling Network of Growth Factor Receptors. Advances in cancer research. 77. 25–79. 460 indexed citations

13.

Klapper, Leah N., Nora Vaisman, Nancy E. Hynes, et al.. (1999). The ErbB-2/HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factors. Proceedings of the National Academy of Sciences. 96(9). 4995–5000. 348 indexed citations

14.

Pinkas‐Kramarski, Ronit, Anne E.G. Lenferink, Sarah Bacus, et al.. (1998). The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin. Oncogene. 16(10). 1249–1258. 75 indexed citations

15.

Klapper, Leah N., Nora Vaisman, Esther Hurwitz, et al.. (1997). A subclass of tumor-inhibitory monoclonal antibodies to ErbB-2/HER2 blocks crosstalk with growth factor receptors. Oncogene. 14(17). 2099–2109. 157 indexed citations

16.

Pinkas‐Kramarski, Ronit, Lior Soussan, Hayley R. Waterman, et al.. (1996). Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions.. The EMBO Journal. 15(10). 2452–2467. 645 indexed citations breakdown →

17.

Klapper, Leah N., et al.. (1996). Thrombin stimulates atrial natriuretic peptide secretion from rat cardiac atrium.. Journal of Pharmacology and Experimental Therapeutics. 278(2). 476–481. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact